A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2. (Q40602227)
Jump to navigation
Jump to search
scientific article published on May 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2. |
scientific article published on May 2001 |
Statements
1 reference
A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2. (English)
1 reference
1 reference
Nadler LM
1 reference
Anderson KC
1 reference
Gilleece MH
1 reference
Gribben JG
1 reference
1 May 2001
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference